In this section, you will find press informations, publications, and other media content from Zyagnum AG.
Press release in german language
Press release in german language
Press release in german language
Press release in german language
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von Vimeo.
Mehr erfahren
TKTL1 Talk With Johannes Coy: “We Will Rethink Medicine.”
Video | 31.05.2023 | 11 Min. (English Subtitles)
TKTL1 discoverer Coy on the opportunities and future of medicine thanks to the latest findings on TKTL1.
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von Vimeo.
Mehr erfahren
The Gene TKTL1: An Interview With Its Discoverer Johannes Coy
Video | 29.03.2023 | 39 Min. (English Subtitles)
Zyagnum AG founder Johannes Coy: 15 answers about the gene that keeps us healthy and yet triggers cancer.
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von Vimeo.
Mehr erfahren
Zyagnum AG: New Standards in Early Detection
Video | 13.02.2023 | 2 Min. (English Subtitles)
Company presentation Zyagnum AG with CEO Ralf Schierl and Scientific Director Oliver Feyen
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von Vimeo.
Mehr erfahren
Krebs-Scan: What Is It and How Does It Work?
Video | 03.10.2022 | 2 Min.
Cancer screening program: A combination of PanTum Detect® blood test and state-of-the-art imaging.
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von YouTube.
Mehr erfahren
Krebs-Scan: The Best Protection for Early Detection
Video | 05.09.2022 | 2 Min.
Krebs-Scan, PanTum Detect®: A customer diagnosed with lung cancer reports.
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von Vimeo.
Mehr erfahren
Pantum Detect® Blood Test: What Is It and How Does It Work?
Video | 01.09.2022 | 2 Min.
An innovative blood test that can provide indications of many types of cancer.
Mit dem Laden des Videos akzeptieren Sie die Datenschutzerklärung von Vimeo.
Mehr erfahren
Krebs-Scan: The Best Protection for Early Cancer Detection
Video | 13.02.2023 | 1:30 Min.
Krebs-Scan, PanTum Detect®: A customer diagnosed with liver cancer reports.
Zyagnum CEO Ralf Schierl in an Interview With Rhein-Main TV
Interview | 03.02.2023 | 7 Min.
Ralf Schierl, CEO of Zyagnum AG, talks about the PanTum Detect® in the TV show “rheinmain IM BLICK”.
Xie, C., Wang, S., Guo, C. et al. Apo10 and TKTL1 in blood macrophages as biomarkers for differentiating lung cancer from benign lung lesions: a comparative study with conventional biomarkers. Cellular Oncology 2023
Burg S.; Smeets R.; Gosau M.; Failing K.; Grust A.: Case Report: Early detection of lung carcinoid in an asymptomatic individual by blood-test initiated PET-CT imaging. Frontiers in Oncology 2023
Li Y.; Xu C.; Wang B.; Xu F.; Ma F. et al.: Proteomic characterization of gastric cancer response to chemotherapy and targeted therapy reveals new therapeutic strategies. nature communications 2022
Pinson A.; Xing L.; Xinnan L.; Namba T.; Kalebic N; Peters J. et al.: Human TKTL1 implies greater neurogenesis in frontal neocortex of modern humans than Neanderthals. Science 2022
Liu Q.; Fangming Z.; Xinnan L.; Ying L.; Ke Y.; Na T.; et al.: Non-oxidative pentose phosphate pathway controls regulatory T cell function by integrating metabolism and epigenetics. nature metabolism 2022
Hao S.; Qingfei, M.; Huihui S.; Yunkuo L.; Yao L.; et al.: The role of transketolase in human cancer progression and therapy. Elsevier 2022
Urla, C.; Stagno, M.J.; Schmidt, A.; Handgretinger, R.; Fuchs, J.; Warmann, S.W.; Schmid, E. Epitope Detection in Monocytes (EDIM) As a New Method of Liquid Biopsy in Pediatric Rhabdomyosarcoma. Biomedicines 2022, 10, 1812.
Burg S, Grust ALC, Feyen O, Failing K, Banat G-A, Coy JF, et al. Blood-Test Based Targeted Visualization Enables Early Detection of Premalignant and Malignant Tumors in Asymptomatic Individuals. Journal of Clinical and Medical Images. 2022;6.
Stagno M, Schmidt A, Bochem J, et al. Epitope detection in monocytes (EDIM) for liquid biopsy including identification of GD2 in childhood neuroblastoma—a pilot study. British Journal of Cancer. 2022;7.
Baptista I, Karakitsou E, Cazier J-B, Günther UL, Marin S, Cascante M. TKTL1 Knockdown Impairs Hypoxia-Induced Glucose-6-phosphate Dehydrogenase and Glyceraldehyde-3-phosphate Dehydrogenase Overexpression. Int J Mol Sci. 2022;23:3574.
Li 2022 | Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation
Li M, Zhao X, Yong H, Xu J, Qu P, Qiao S, et al. Transketolase promotes colorectal cancer metastasis through regulating AKT phosphorylation. Cell Death Dis. 2022;13:99.
Niu C, Qiu W, Li X, Li H, Zhou J, Zhu H. Transketolase Serves as a Biomarker for Poor Prognosis in Human Lung Adenocarcinoma. J Cancer. 2022;13:2584–93.
Zhang L, Huang Z, Cai Q, Zhao C, Xiao Y, Quan X, et al. Inhibition of Transketolase Improves the Prognosis of Colorectal Cancer. Front Med. 2022;9:837143.
PDF document with further information on the study background. (german)
Burg S, Grust ALC, Feyen O, Failing K, Banat G-A, Coy JF, et al. Blood-Test Based Targeted Visualization Enables Early Detection of Premalignant and Malignant Tumors in Asymptomatic Individuals. Journal of Clinical and Medical Images. 2022;6.
Here you can download graphics related to the UKE study 06/2022.
Zyagnum logos in different versions for download
PanTum Detect® logo in different versions for download.
All copyrights and distribution rights to the images on this website are owned by Zyagnum AG. The use of images requires the written permission of Zyagnum AG and the indication of the source “© Zyagnum AG 2023, all rights reserved”. Please inform us about the use of images from our library before publication by sending an e-mail to info@zyagnum.com.
Images may not be altered or combined in any way with other images. Permanent storage on electronic systems is not permitted.